Pre-planning is key to achieving the most optimal clinical outcomes for patients with multiple challenging risk factors or individual characteristics.
New research shows that obstetricians may need to rethink how they screen certain patients for gestational diabetes mellitus.
New research presented at ACOG 2014 shows that inadequate weight gain in the second trimester is an independent risk factor for spontaneous preterm birth.
A history of gestational diabetes could be a risk factor for later heart disease, highlighting that reproductive complications may unmask future disease risk.
Physicians’ groups are urging ob/gyns to have difficult conversations with obese women about their weight. Here’s one example of how utter bluntness can be an effective tactic.
Women who have had bariatric surgery require special care during pregnancy, particularly with assessment of micronutrient deficiencies and appropriate replacement. Here’s one ob/gyn’s approach.
All pregnant women should be tested for diabetes by 13 weeks’ gestation and tested again for gestational diabetes between 24 and 28 weeks’ gestation, say new guidelines.
Low levels of adiponectin before pregnancy were associated with a 5-fold increased risk of gestational diabetes. This risk was 7-fold in obese or overweight women.
The current treatment of mild gestational diabetes mellitus results in fewer cases of preeclampsia, shoulder dystocia, and macrosomia but seems to have no effect on neonatal hypoglycemia or future poor metabolic outcomes, concluded a systematic review and meta-analysis.
In patients with gestational diabetes mellitus, metformin is an effective alternative to insulin, according to the findings of a recent single-center randomized controlled study.